beta
/Long-term Function and Survival of Radicava ORS® (Oral Edaravone)-Treated Patients With ALS vs Propensity Score–Matched PRO-ACT Historical Controls (P8-2.003)

Reviews

Join the dialogue

Submit a peer review to improve the scientific record

Summary